.Pharmacolibrary.Drugs.ATC.J.J07CA10 .Pharmacolibrary.Drugs.ATC.J.J07CA10| name: | TyphoidHepatitisA | |
| ATC code: | J07CA10 | |
| route: | intramuscular | |
| compartments: | 1 | |
| dosage: | 1 | mg |
| volume of distribution: | 1 | L |
| clearance: | 0 | |
| other parameters in model implementation | ||
Combined typhoid and hepatitis A vaccine (ATC J07CA10) is used for immunization against both typhoid fever (caused by Salmonella typhi) and hepatitis A virus infection. It is a modern vaccine preparation often used for travelers to regions with risk for these infections and is an approved medication.
No published pharmacokinetic (PK) studies with detailed PK parameter reporting for the combined typhoid-hepatitis A vaccine were identified. As this is an inactivated vaccine product, standard PK parameters like bioavailability, clearance, volume of distribution are generally not reported.